Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Phibro Animal Health (PAHC) over the last 13 years, with Q4 2025 value amounting to -$19.0 million.

  • Phibro Animal Health's Cash from Financing Activities fell 10686.88% to -$19.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$42.6 million, marking a year-over-year decrease of 11680.06%. This contributed to the annual value of $207.1 million for FY2025, which is 316049.05% up from last year.
  • According to the latest figures from Q4 2025, Phibro Animal Health's Cash from Financing Activities is -$19.0 million, which was down 10686.88% from $16.3 million recorded in Q3 2025.
  • In the past 5 years, Phibro Animal Health's Cash from Financing Activities ranged from a high of $276.3 million in Q4 2024 and a low of -$32.2 million during Q1 2025
  • Over the past 5 years, Phibro Animal Health's median Cash from Financing Activities value was $1.5 million (recorded in 2023), while the average stood at $11.7 million.
  • Over the last 5 years, Phibro Animal Health's Cash from Financing Activities had its largest YoY gain of 197908.87% in 2024, and its largest YoY loss of 235285.49% in 2024.
  • Phibro Animal Health's Cash from Financing Activities (Quarter) stood at -$14.6 million in 2021, then soared by 125.49% to $3.7 million in 2022, then crashed by 495.72% to -$14.7 million in 2023, then soared by 1979.09% to $276.3 million in 2024, then crashed by 106.87% to -$19.0 million in 2025.
  • Its last three reported values are -$19.0 million in Q4 2025, $16.3 million for Q3 2025, and -$7.8 million during Q2 2025.